Filter
450
Text search:
Neurology
Featured
Recommendations
49
New Publications
72
Language
Document type
No document type
306
Studies & Reports
47
Guidelines
32
Manuals
25
Training Material
18
Strategic & Response Plan
11
Fact sheets
6
Situation Updates
2
Brochures
1
Resource Platforms
1
Online Courses
1
Countries / Regions
India
26
Ukraine
16
Russia
16
Western and Central Europe
15
Brazil
11
Latin America and the Carribbean
10
Eastern Europe
10
Africa
9
Germany
8
Syria
7
Asia
7
Nepal
5
South Africa
5
Bangladesh
5
Global
5
Cameroon
4
Sierra Leone
3
Liberia
3
Nigeria
3
Ethiopia
3
Uganda
3
West and Central Africa
3
Middle East and North Africa
3
USA
2
Philippines
2
South Sudan
2
Kenya
2
Tanzania
2
Rwanda
2
Chile
2
East and Southern Africa
2
South–East Asia Region
2
Vietnam
2
France
2
Portugal
2
Spain
2
Guinea
1
Congo, Democratic Republic of
1
Ghana
1
Afghanistan
1
Zambia
1
Turkey
1
Egypt
1
China
1
Indonesia
1
Malawi
1
Mozambique
1
Argentina
1
Hungary
1
Colombia
1
Bolivia
1
Angola
1
Myanmar / Burma
1
Eastern Europe and Central Asia
1
Other region
1
Bhutan
1
Poland
1
Italy
1
Estonia
1
Romania
1
Moldova
1
Slovakia
1
Iran
1
Japan
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
88
Clinical Guidelines
46
Public Health
16
Women & Child Health
12
Capacity Building
5
Key Resources
4
Pharmacy & Technologies
2
Toolboxes
Mental Health
219
Disability
40
COVID-19
38
Zika
22
Conflict
10
Rapid Response
10
Refugee
9
HIV
8
Planetary Health
8
NCDs
7
Ebola
6
Caregiver
6
NTDs
6
Natural Hazards
4
Global Health Education
3
Pharmacy
3
Health Financing Toolbox
2
TB
1
AMR
1
Social Ethics
1
16-17 march 2015, Geneva, Switzerland
Meeting report
Bull World Health Organ 2013;91:773–783 | doi: http://dx.doi.org/10.2471/BLT.13.118422
(Submitted: 15 February 2013 – Revised version received: 21 June 2013 – Accepted: 22 June 2013 – Published online: 20 August 2013)
Q 10: In adults and children with epilepsy, which psychological interventions used as adjunctive therapies with antiepileptic drugs when compared to placebo/comparator produce benefits/harm in specified outcomes?
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
Q6: What is the added advantage of doing neuroimaging in people with convulsive epilepsy in non-specialist settings in low and middle income countries?
Q3: Can febrile seizures (simple or complex) be managed at first or second level care by non-specialist health care providers in low and middle income country settings? What is the role of diagnostic tests in the management of febrile seizures by non-specialists in low and middle income settings? Fo
...
Q5: What is the added advantage of doing an electroencephalography (EEG) in people with convulsive epilepsy in non- specialist settings in low and middle income countries?
Q8. Should Anti-Epileptic Drug (AED) treatment be started after first unprovoked seizure in non-specialist health settings?
Q4: Can convulsive epilepsy be diagnosed at first level care by a non-specialist health care provider in low and middle income country settings?
SCOPING QUESTION: In adults with acute convulsive seizures, where intravenous access is available, which first-line anti- epileptic medication should be used to abort seizures when compared to comparator?
[Updated 2015]
Scoping Question: In adults with acute convulsive seizures in first-level care or in the community (when no IV access is available), which antiepileptic medications produce benefits and/or harm when compared to comparator?
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
SCOPING QUESTION: In adults with established status epilepticus (i.e., seizures persisting after the first-line treatment with benzodiazepines [or benzodiazepines-resistant status epilepticus]), which anti-epileptic medications are associated with cessation of seizures and reduced adverse effects)?
...
Q12: Should the treatment be similar in individuals with intellectual disability and epilepsy compared to people with epilepsy only?
Q11: 11a). In women with epilepsy, should antiepileptic therapy be prescribed as monotherapy or polytherapy to decrease the risk of fetal malformations?
11b). Does the use of folic acid preconceptually decrease the risk of foetal malformations in women with epilepsy?
11c). Do phenytoin, phenobarbi
...
Out of the shadows
What you can do
Arq Neuropsiquiatr 2011;69(2-B):342-348
Цель настоящего доклада — повысить осведомленность о деменции как
одной из приоритетных проблем общественного здравоохранения, сформу-
лировать подход к этой п
...
Int J Crit Illn Inj Sci. 2012 May-Aug; 2(2): 82–97.
doi: 10.4103/2229-5151.97273
PMCID: PMC3401822
PMID: 22837896
